Intralipid and liver function test abnormal Patient Reports February 09, 2010

Intralipid Side Effects Report #4556545-7
Intralipid side effect was reported by a Pharmacist from on Sept 17, 2004. Male patient, child 6 years of age, weighting 53.13 lb, was diagnosed with malabsorption and was treated with Intralipid. After drug was administered, patient experienced the following side effects: disseminated intravascular coagulation, haemorrhage, liver function test abnormal, viral infection . Intralipid dosage: 220 ML/- DAILY / INTRAVENOUS IN. During the same period patient was treated with DEXTROSE, TRAVASOL, NORMAL SALINE, K ACETATE. Patient was hospitalized. Patient recovered.

Intralipid Side Effects Report #4556542-1
Intralipid side effect was reported by a Pharmacist from on Sept 17, 2004. Female patient, child 4 years of age, weighting 36.38 lb, was diagnosed with malabsorption and was treated with Intralipid. After drug was administered, patient experienced the following side effects: catheter related infection, disseminated intravascular coagulation, liver function test abnormal. Intralipid dosage: 200 ML/- DAILY/ INTRAVENOUS IN. During the same period patient was treated with DEXTROSE, TROPHAMINE, ZANTAC. Patient died on 08/29/2004.

Intralipid Side Effects Report #4599391-0
Intralipid side effect was reported by a Pharmacist from on Mar 03, 2005. Female patient, 81 years of age, weighting 152.1 lb, was diagnosed with gastrointestinal disorder and was treated with Intralipid. After drug was administered, patient experienced the following side effects: liver function test abnormal. Intralipid dosage: 50 MLS/HOUR DAILY FOR 10 H OTHER. Patient recovered.

Intralipid Side Effects Report #4556550-0
Intralipid side effect was reported by a Pharmacist from on Sept 17, 2004. Male patient, weighting 13.23 lb, was diagnosed with congenital intestinal malformation and was treated with Intralipid. After drug was administered, patient experienced the following side effects: blood bilirubin increased, blood bilirubin unconjugated increased, liver function test abnormal. Intralipid dosage: 33 ML/ 1 DAILY/ INTRAVENOUS INF. During the same period patient was treated with DEXTROSE, TROPHAMINE, CYSTEINE, ZANTAC. Patient recovered.